№ lp_2_3_52760
File format: docx
Character count: 3477
File size: 18 KB
Structured peer review questionnaire outlining workforce, infrastructure, clinical pathways, audit processes and patient-related aspects of a multidisciplinary diabetic footcare service within a UK healthcare setting.
Type of document:
Clinical service peer review questionnaire
Subject:
Multidisciplinary diabetic footcare services
Healthcare context:
Secondary and community care
Reference standards:
NICE NG19; National Diabetes Footcare Audit
Geographical context:
United Kingdom
Target audience:
MDFT members; healthcare professionals; service managers
Clinical areas covered:
Vascular surgery; orthopaedics; podiatry; infection management; outpatient and inpatient care
Service components:
Infrastructure; workforce; capacity; pathways; patient education; audit and outcomes
Time frame referenced:
Last 12 months; next five years
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2012
Revision date:
October 2018
Region / City:
Exeter, Mid & East Devon
Country:
United Kingdom
Document type:
Clinical pathway
Subject:
Diabetic foot care and referral criteria
Clinical area:
Primary care and podiatry
Organisations:
Royal Devon and Exeter NHS Foundation Trust; RDUH; Diabetes UK; National Institute for Health and Care Excellence; Scottish Diabetes Group – Foot Action Group
Authors:
RD&E diabetic foot clinic and Community Podiatry Team
Guideline basis:
NICE NG19 (2016) and Scottish Diabetes Group – Foot Action Group 2016
Target audience:
Primary care professionals and referral services
Referral services mentioned:
RD&E Foot Clinic; Community Podiatry; Vascular Team; Medical Admissions
Contact details included:
[email protected]
Scope:
Risk assessment, referral criteria, emergency admission indications, and follow-up intervals for diabetic foot conditions
Year:
2026
Region / City:
Cambridgeshire and Peterborough, UK
Type of Document:
Application Form
Organization:
Feet Focus Community Footcare / NHS
Target Audience:
Low and medium risk patients requiring footcare
Date of Issue:
2026
Contact Email:
[email protected]
Telephone:
03307 260077
Referral Sources:
Self, GP, Other
Medical Information Required:
Yes
Appointment Reminders:
Optional via text message
Addresses for Submission:
Huntingdon, Peterborough, East Cambs/Fenland, Cambridge/South Cambs
Year:
2025
Date:
7 April 2025
Region / City:
Swindon and Wiltshire, Gloucestershire
Country:
United Kingdom
Healthcare System:
NHS
Clinical Area:
Diabetes foot care
Topic:
Diabetic foot ulcer referral pathways
Document Type:
Clinical referral guidance and referral form
Issuing Organizations:
Gloucestershire Hospitals NHS Foundation Trust; Wiltshire Community Podiatry; Swindon Community Podiatry
Target Audience:
General practitioners, community podiatrists, healthcare professionals
Referral Pathways:
Same Day Emergency Care (SDEC); Foot Attack Clinic; Community Podiatry; Vascular Surgery
Urgency Categories:
Urgent referrals; Routine referrals
Associated Services:
Diabetes Foot MDT; Community Diabetes Teams
Clinical Conditions Covered:
Diabetic foot ulceration; infection; ischaemia; Charcot foot; neuropathy
Required Clinical Information:
Patient demographics; diabetes history; comorbidities; ulcer characteristics; investigations; treatments
Investigations Referenced:
Blood tests; wound swab; tissue sample; X-ray; ultrasound
Contact Methods:
Email referrals; ERS submissions; telephone
Period of Applicability:
Ongoing as of April 2025
Year:
2020
Region / City:
Australia
Topic:
Medical Treatment, Pharmaceutical
Document Type:
Submission
Organ / Institution:
Novartis Pharmaceuticals Australia Pty Limited
Author:
Not specified
Target Audience:
Healthcare professionals, policymakers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2021
Region / City:
UK
Topic:
Diabetic Ketoacidosis Management
Document Type:
Guideline
Organization / Institution:
BSPED
Author:
BSPED Special Interest Group
Target Audience:
Healthcare professionals, Pediatricians, Medical teams
Period of Validity:
Ongoing
Approval Date:
2021
Revision Date:
2021
Changes Date:
May 2021
Note:
Context description
Year:
2023
Region / City:
Europe
Topic:
Diabetic foot complications, imaging
Document type:
Clinical guideline / Consensus statement
Organization:
European Association of Nuclear Medicine (EANM)
Authors:
Chiara Lauri, Edel Noriega-Álvarez, Riddhika M. Chakravartty, Olivier Gheysens, A.W.J.M Glaudemans, Riemer H.J.A. Slart, Thomas C. Kwee, Frédéric Lecouvet, Emmanouil Panagiotidis, Jules Zhang-Yin, Jose Luis Lazaro Martinez, Benjamin A. Lipsky, Luigi Uccioli, Alberto Signore
Target audience:
Nuclear medicine physicians, radiologists, diabetologists, podiatrists, infectious disease specialists
Methods:
Evidence-based recommendations using PICO strategy and Oxford Centre for Evidence-based Medicine criteria
Clinical focus:
Osteomyelitis, soft tissue infection, Charcot foot
Imaging modalities:
MRI, WBC scintigraphy, PET/CT, X-ray, SPECT/CT
Endorsing body:
EANM Inflammation and Infection Committee, Bone & Joint Committee
Description:
Evidence-based clinical guideline detailing the preferred imaging strategies for diagnosing infective and non-infective complications in diabetic foot, including osteomyelitis and soft tissue infections, based on consensus from nuclear medicine, radiology, and clinical experts.
Year:
2021
Region / City:
Ontario
Subject:
Diabetic foot ulcers, prevention, assessment, management
Document Type:
Guideline
Author:
Expert panel on diabetic foot care
Target Audience:
Healthcare providers, long-term care organizations
Period of Application:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Programme:
GMS Diabetic Eye Screening Programme
Date:
3rd August 2023
Region:
Greater Manchester
Areas Covered:
Manchester; Salford; Stockport; Tameside & Glossop; Trafford
Document Type:
Official venue list
Subject:
Diabetic eye screening locations
Contact Telephone:
01614 643000
Responsible Unit:
The Bookings Team
Access Information:
D = Disabled; S = Scooter; W = Wheelchair
Screening Settings:
Community centres; opticians; health centres; churches; libraries; mobile clinics
Year:
2024-2025
Region / city:
Moshi, Tanzania
Subject:
Diabetic Macular Edema, Intravitreal Bevacizumab
Document Type:
Research Article
Organization / Institution:
Kilimanjaro Christian Medical Centre (KCMC)
Author:
Not specified
Target Audience:
Healthcare professionals, researchers in ophthalmology
Period of Application:
June 2024 - July 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Guangzhou, P. R. China
Subject:
Biomedical research, wound healing
Document Type:
Research article
Author:
Biyun Lan, Liming Zhang, Liqun Yang, Junfeng Wu, Na Li, Chenglin Pan, Xiaoyi Wang, Lexiang Zeng, Li Yan, Chuan Yang, Meng Ren
Target Audience:
Researchers in biomedical science, pharmaceutical development, and tissue engineering
Effective Period:
Ongoing study
Approval Date:
2026
Modification Date:
Not specified
Keywords:
MMP-9, siRNA, diabetic wound healing, thermosensitive hydrogel, bioengineering
Year:
2021
Region / City:
Singapore
Theme:
Diabetes management, Foot care
Document Type:
Course syllabus
Organization:
NHGP
Target Audience:
Primary care nurses, Healthcare professionals
Period of validity:
August 2021 - November 2021
Approval Date:
31 August 2021
Amendment Date:
23 November 2021
Year:
2020
Country:
Australia
Therapeutic Area:
Ophthalmology
Indication:
Diabetic macular oedema (DMO)
Active Substance:
Fluocinolone acetonide 190 microgram intravitreal implant
Brand Name:
Iluvien®
Sponsor:
Specialised Therapeutics Alim Pty Ltd
Regulatory Authority:
Pharmaceutical Benefits Advisory Committee (PBAC)
Registration Status:
TGA registered on 29 July 2019
Type of Submission:
Minor resubmission
Type of Analysis:
Cost-minimisation analysis (CMA)
Comparator:
Dexamethasone intravitreal implant
Restriction Level:
Authority Required – In Writing Only
Treatment Phase:
Initial treatment
Prescriber Type:
Medical practitioners, nurse practitioners, optometrists, midwives, dental practitioners
Program Category:
General Schedule (Code GE)
Clinical Criteria:
Visual impairment due to DMO with specified visual acuity range and prior corticosteroid treatment without significant intraocular pressure rise
Population Criteria:
Patients post-cataract surgery or scheduled for cataract surgery in the treated eye
Document Type:
Public Summary Document extract
Year:
2021
Region / City:
Chennai, India
Topic:
Dental health in diabetic patients
Document Type:
Research article
Author:
D. Madhumathi, Dr. Arvina
Target Audience:
Researchers, healthcare professionals
Period of Action:
Not specified
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
Shimla
Topic:
Diabetic Peripheral Neuropathy, Shear Wave Elastography
Document Type:
Research Study
Institution:
Indira Gandhi Medical College, Shimla
Author:
Not mentioned
Target Audience:
Healthcare professionals, researchers
Period of Validity:
January 2024 - May 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Keywords:
Diabetic Peripheral Neuropathy, Shear Wave Elastography, Nerve Conduction Studies, Ultrasonography, Tibial Nerve
Context:
This research paper evaluates the effectiveness of Shear Wave Elastography (SWE) in diagnosing Diabetic Peripheral Neuropathy (DPN), comparing it with traditional methods like Nerve Conduction Studies (NCS) and ultrasonography.
Year:
2025
Region / City:
Not specified
Topic:
Diabetic Peripheral Neuropathy management
Document Type:
Clinical case series
Organization / Institution:
Unani Medicine Department / In-Patient Department
Author:
Not specified
Target Audience:
Healthcare professionals and researchers
Treatment Evaluated:
Qurse Ziabetas Khas (QZK) and Habb-e-Azaraqi (HA)
Patient Population:
Adults with Type 2 Diabetes Mellitus and DPN
Number of Cases:
3
Duration of Intervention:
56 days
Assessment Methods:
Toronto Clinical Neuropathy Score, Vibration Perception Threshold, Visual Analogue Scale, HbA1c, WHOQOL-BREF
Outcomes:
Neuropathic symptom relief, improved glycemic control, enhanced quality of life
Adverse Events:
None reported
Contextual Description:
Case series reporting clinical outcomes of three male patients with diabetic peripheral neuropathy treated with Unani formulations QZK and HA alongside conventional therapy.
Year:
2026
Region / City:
Brussels, Belgium; Xinyang, China
Subject:
Biomedical research, diabetic wound treatment, nanotechnology
Document type:
Review article
Institution:
Université libre de Bruxelles; Xinyang Normal University
Authors:
Man Li, Hafez Jafari, Oseweuba Valentine Okoro, Lei Nie, Armin Shavandi
Target audience:
Researchers, clinicians, biomedical engineers
Keywords:
Nanozymes, diabetic wounds, catalytic antibacterial activity, reactive oxygen species, wound healing
Summary:
Comprehensive overview of nanozyme types, mechanisms, and applications in accelerating diabetic wound healing
Challenges:
Drug-resistant bacteria, chronic inflammation, high blood glucose environment
Applications:
Antibacterial therapy, oxidative stress modulation, enzymatic glucose reduction